Arcturus Therapeutics Holdings Inc
ARCT
Market Cap$373.72M
Close$
$-26.42
295.1% downside
Current Fair Value
295.1% downsideOvervalued by 295.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $373.72 Million |
|---|---|
| Enterprise Value | $214.61 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3 |
| Beta | 2.29 |
| Outstanding Shares | 27,107,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -5.48 |
|---|---|
| PEG | 11.53 |
| Price to Sales | 2.71 |
| Price to Book Ratio | 1.69 |
| Enterprise Value to Revenue | 1.55 |
| Enterprise Value to EBIT | -4.39 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.27 |
| Debt to Equity | 0.25 |
Revenue Sources
No data
Insider Trades
ESG Score
No data